id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-272715-33c85eaa	Ma, R. C. W.	COVID‐19 and diabetes	2020-04-03		.txt	text/plain	1244	70	50	Whether people with diabetes have a higher susceptibility to COVID-19 is currently unknown, but there is a perception that the risk is higher both of infection and severe disease. It is currently unknown why people with diabetes, hypertension or other chronic diseases are more severely affected by COVID-19, but one possible explanation involves angiotensin-converting enzyme 2 (ACE2). In a similar manner to the coronavirus that caused Severe Acute Respiratory Syndrome (SARS-CoV), the novel coronavirus responsible for COVID-19 utilizes ACE2 on the surfaces of epithelial cells to bind and gain entry to infected cells [4, 5] . A recent position statement from the European Society of Cardiology also strongly recommends that physicians and patients continue treatment with their usual anti-hypertensive treatment and that there is no clinical or scientific evidence to suggest that treatment with ACE inhibitors or ARBs should be discontinued because of the COVID-19 infection [9] .	./cache/cord-272715-33c85eaa.txt	./txt/cord-272715-33c85eaa.txt